CAS 2001559-19-7

6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile

CAS : 2001559-19-7

Formule : C₁₈H₁₂ClFN₆O

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 382.7789

Ref: IN-DA01KJZS

BMS986260

CAS : 2001559-19-7

BMS986260

Degré de pureté : ≥95%

Masse moléculaire : 382.78g/mol

Ref: 54-BUP03048

6-(4-(3-Chloro-4-Fluorophenyl)-1-(2-Hydroxyethyl)-1H-Imidazol-5-Yl)Imidazo[1,2-B]Pyridazine-3-Carbonitrile

CAS : 2001559-19-7

6-(4-(3-Chloro-4-Fluorophenyl)-1-(2-Hydroxyethyl)-1H-Imidazol-5-Yl)Imidazo[1,2-B]Pyridazine-3-Carbonitrile

Degré de pureté : 97%

Masse moléculaire : 382.78g/mol

Ref: 54-PC108581

BMS986260

CAS : 2001559-19-7

BMS-986260 is a selective, and orally bioavailable TGFβR1 inhibitor(IC50 = 1.6 nM).

Formule : C₁₈H₁₂ClFN₆O

Degré de pureté : 97.67%

Couleur et forme : Solid

Masse moléculaire : 382.78

Ref: TM-T8730

6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile

CAS : 2001559-19-7

6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine-3-carbonitrile is a potent and selective inhibitor of human Kv1.3 channels. This compound has been shown to inhibit the activation of human T lymphocytes by inhibiting Kv1.3 channels. 6-(4-(3-Chloro-4-fluorophenyl)-1-(2-hydroxyethyl)-1H-imidazol-5-yl)imidazo[1,2-b]pyridazine has also been shown to be a potential research tool for studying ion channels and their role in cell biology.

Formule : C₁₈H₁₂ClFN₆O

Degré de pureté : Min. 95%

Masse moléculaire : 382.8 g/mol

Ref: 3D-BFD55919